Latest Investor Confidence News

Horizon Gold has successfully completed its renounceable entitlement issue, raising nearly $7 million including a full shortfall placement, positioning the company for further development at its Gum Creek Gold Project.

Corporate Travel Management Limited’s shares remain suspended on the ASX as the company delays lodging its Preliminary Final Report amid ongoing financial restatement concerns.

Evolution Energy Minerals Limited’s EV1O securities have been suspended from ASX quotation due to non-compliance with a key listing rule, raising questions about the company’s regulatory standing.

MAC Copper Limited shareholders have decisively approved the proposed acquisition by Harmony Gold, clearing a major hurdle for the transaction. The scheme now awaits final court sanction before becoming effective.

Halo Technologies Holdings Ltd reported a $6.06 million half-year loss, narrowing from last year’s $8.04 million, while preparing an $11 million rights issue to bolster its finances amid auditor concerns over asset valuations.

Rewardle Holdings reports a sharp 497% increase in half-year losses amid strategic investments in its MedTech partner CloudHolter and fintech expansions. Despite financial headwinds, the company advances its B2B2C platform with a focus on growth and innovation.

Mayfield Childcare reported a 14.9% revenue increase driven by acquisitions but suffered a steep $21.9 million net loss, with auditors flagging related party disclosure issues.

Astron Limited has finalized its move from Hong Kong to Australia, issuing new securities on a two-for-one basis and preparing for ASX trading starting September 1, 2025.

Perpetual Resources has launched a prospectus to enable trading of new options issued alongside a recent $1.6 million placement, aiming to unlock liquidity while outlining key risks for investors.

Argent BioPharma reported a net loss of A$17.84 million for FY2025, reflecting a strategic pivot towards core drug development and clinical advancement. The company secured key EU approvals and raised significant capital to support its neuro-immune modulatory pipeline.

Spenda Limited reported a 106% surge in revenue to $11.1 million for FY25, driven by acquisitions and expanded services, yet posted a substantial $24.3 million net loss largely due to goodwill impairment. The company’s strategic moves and funding needs highlight a pivotal phase ahead.

Duxton Water Limited has declared its 17th consecutive dividend increase at 3.72 cents per share, fully franked, while removing the discount on its Dividend Reinvestment Plan following a major debt repayment.